Brain radiation study tracking thinking and memory changes
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how whole-brain radiation affects thinking, memory, and other brain function in people with blood cancers that involve the brain. It may help doctors understand what to expect and which supportive treatments or monitoring could be useful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have received radiation to the whole brain for a blood cancer that has spread to the brain (or started in the brain)
- Be able to do the study tests in English
- If you have claustrophobia (fear in enclosed spaces), you can still join if it can be controlled with medication
- If you have trouble with thinking or memory, you can still join if it can be controlled with medication
- You can join if you are pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how newly diagnosed primary central nervous system (brain) non-Hodgkin lymphoma responds to a specific type of radiation to the whole brain, and it also looks at changes in thinking, mood, and behavior. It may help doctors understand how this treatment affects day-to-day brain function.
This study looks at whether treatments that boost the immune system to fight blood cancers might affect thinking and memory. Researchers will track cognitive (thinking and memory) changes in patients receiving cell-based or antibody-based immunotherapies to understand any side effects and help future patients.
This study looks at how cancer and its treatment affect thinking and memory. It may help find ways to protect brain function during radiotherapy.
This trial looks at the immune system and metabolism of people with primary central nervous system lymphoma (a type of brain cancer) to find differences that might help with future treatments. It does not test a new drug, but collects samples and medical information.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
This study checks how people’s thinking and brain functioning change while they are getting radiation therapy for head and neck cancer. It uses simple computer tests and questionnaires to better understand who may be at risk for trouble thinking during treatment.
Hear when a new Central Nervous System Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.